Skip to main content
Top
Published in: Surgery Today 4/2015

01-04-2015 | Original Article

The fate of ischemic limbs in patients with Buerger’s disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs?

Authors: Masayuki Sugimoto, Hiroki Miyachi, Hirofumi Morimae, Akio Kodama, Hiroshi Narita, Hiroshi Banno, Kiyohito Yamamoto, Kimihiro Komori

Published in: Surgery Today | Issue 4/2015

Login to get access

Abstract

Purpose

We herein review the long-term results of our series of critical ischemic limbs caused by Buerger’s disease.

Methods

A retrospective review of 103 patients with critical limb ischemia who were diagnosed with Buerger’s disease by Shionoya’s criteria between 1980 and 2010.

Results

The age of onset was 38.0 ± 9.7 years (mean ± SD). The median follow-up was 97 months. Thirty-three patients had pain at rest, and 65 patients presented with ischemic ulcers in their toes and/or fingers. Gangrene was present in five patients. Sixteen patients achieved remission with medical therapy and smoking cessation. Sixty-six patients underwent sympathectomy. Bypass to the crural arteries was performed in 23 limbs, with assisted primary patency rates of 67.0 and 45.6 % at five and 10 years. Graft failure caused major amputation in two out of 10 smokers, but no limbs were lost among the 12 ex-smokers. Therapeutic angiogenesis using cell transplantation led to improvement in three ex-smokers; however, amputation was unavoidable in the one smoker who was treated. The limb salvage rate at 20 years was 90 % in ex-smokers and 69 % in smokers, which was not significantly different.

Conclusions

This study demonstrated no significant difference in the limb salvage rate between ex-smokers and smokers. Our results do not support any advantageous effect of smoking cessation on the long-term remission in patients with Buerger’s disease.
Literature
1.
go back to reference Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger’s disease in Japan. Surgery. 1998;124:498–502.CrossRefPubMed Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger’s disease in Japan. Surgery. 1998;124:498–502.CrossRefPubMed
2.
go back to reference Kobayashi M, Nishikimi N, Komori K. Current pathological and clinical aspects of Buerger’s disease in Japan. Ann Vasc Surg. 2006;20:148–56.CrossRefPubMed Kobayashi M, Nishikimi N, Komori K. Current pathological and clinical aspects of Buerger’s disease in Japan. Ann Vasc Surg. 2006;20:148–56.CrossRefPubMed
3.
go back to reference Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5–67.CrossRefPubMed Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5–67.CrossRefPubMed
5.
go back to reference Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–38.CrossRefPubMed Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–38.CrossRefPubMed
6.
go back to reference Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427–35.CrossRefPubMed Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427–35.CrossRefPubMed
7.
go back to reference Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (therapeutic angiogenesis by cell transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 2008;156:1010–8.CrossRefPubMed Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (therapeutic angiogenesis by cell transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 2008;156:1010–8.CrossRefPubMed
8.
go back to reference Shigematsu H, Shigematsu K. Factors affecting the long-term outcome of Buerger’s disease (thromboangiitis obliterans). Int Angiol. 1999;18:58–64.PubMed Shigematsu H, Shigematsu K. Factors affecting the long-term outcome of Buerger’s disease (thromboangiitis obliterans). Int Angiol. 1999;18:58–64.PubMed
9.
go back to reference Nishikimi N. Fate of limbs with failed vascular reconstruction in Buerger’s disease patients. Int J Cardiol. 2000;75(Suppl 1):S183–5.CrossRefPubMed Nishikimi N. Fate of limbs with failed vascular reconstruction in Buerger’s disease patients. Int J Cardiol. 2000;75(Suppl 1):S183–5.CrossRefPubMed
10.
go back to reference Sasajima T, Kubo Y, Inaba M, Goh K, Azuma N. Role of infrainguinal bypass in Buerger’s disease: an eighteen-year experience. Eur J Vasc Endovasc Surg. 1997;13:186–92.CrossRefPubMed Sasajima T, Kubo Y, Inaba M, Goh K, Azuma N. Role of infrainguinal bypass in Buerger’s disease: an eighteen-year experience. Eur J Vasc Endovasc Surg. 1997;13:186–92.CrossRefPubMed
11.
12.
go back to reference Ohta T, Ishioashi H, Hosaka M, Sugimoto I. Clinical and social consequences of Buerger disease. J Vasc Surg. 2004;39:176–80.CrossRefPubMed Ohta T, Ishioashi H, Hosaka M, Sugimoto I. Clinical and social consequences of Buerger disease. J Vasc Surg. 2004;39:176–80.CrossRefPubMed
13.
go back to reference Matsushita M, Shionoya S, Matsumoto T. Urinary cotinine measurement in patients with Buerger’s disease–effects of active and passive smoking on the disease process. J Vasc Surg. 1991;14:53–8.CrossRefPubMed Matsushita M, Shionoya S, Matsumoto T. Urinary cotinine measurement in patients with Buerger’s disease–effects of active and passive smoking on the disease process. J Vasc Surg. 1991;14:53–8.CrossRefPubMed
Metadata
Title
The fate of ischemic limbs in patients with Buerger’s disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs?
Authors
Masayuki Sugimoto
Hiroki Miyachi
Hirofumi Morimae
Akio Kodama
Hiroshi Narita
Hiroshi Banno
Kiyohito Yamamoto
Kimihiro Komori
Publication date
01-04-2015
Publisher
Springer Japan
Published in
Surgery Today / Issue 4/2015
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-0904-6

Other articles of this Issue 4/2015

Surgery Today 4/2015 Go to the issue